SMNR · Semnur Pharmaceuticals, Inc.
$0.62
-0.03 (-4.62%)
At close · Jul 29
Going-concern doubt
— flagged May 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, management has concluded that the aforementioned conditions, among other things, raise substantial doubt about the Company's ability to continue as a going concern for one year after the date the condensed consolidated financial statements are issued.”View the 10-Q filed May 13, 2026
Market Cap
$163.45M
Shares
230.21M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2025-06-30 YTD | $8,617,553 | 10-Q, filed 2025-08-15 |
| 2024-12-31 | $43,425,328 | 10-K, filed 2025-04-02 |
| 2023-12-31 | $40,536,908 | 10-K, filed 2025-04-02 |